Skip to main content
Top
Published in: Clinical Rheumatology 11/2019

01-11-2019 | Knee Osteoarthritis | Original Article

Does symptomatic knee osteoarthritis increase the risk of all-cause mortality? Data from four international population-based longitudinal surveys of aging

Authors: Zidan Yang, Guanghua Lei, Xiaoxiao Li, Yilun Wang, Zikun Xie, Xiurui Zhang, Yuchen He, Yilin Xiong, Tubao Yang

Published in: Clinical Rheumatology | Issue 11/2019

Login to get access

Abstract

Objective

This study aimed at examining the association between symptomatic knee osteoarthritis and all-cause mortality based on four population-based longitudinal surveys.

Method

Data were retrieved from the English Longitudinal Study of Aging (ELSA), the Survey of Health, Aging and Retirement in Europe (SHARE), the Korean Longitudinal Study of Aging (KLoSA), and the Indonesian Family Life Survey (IFLS). The association between symptomatic knee osteoarthritis and all-cause mortality over the 8- to 12-year follow-up period was assessed using Cox-proportional hazard models.

Results

In the entire sample of 59,522 participants (4823 with symptomatic knee osteoarthritis; 54,699 without symptomatic knee osteoarthritis [control group]; mean age: 61.8 years; female percentage: 55.3%), 8375 died (937 in the symptomatic knee osteoarthritis group, 7438 in the control group) during the follow-up period. Patients with symptomatic knee osteoarthritis had a higher risk of all-cause mortality than control group without adjusting for potential confounders in each survey, and the unadjusted hazard ratios (HRs) of all-cause mortality were 1.32 (95% confidence interval [CI] 1.18 to 1.47) in ELSA, 1.40 (95%CI 1.24 to 1.56) in SHARE, 1.25 (95%CI 1.06 to 1.47) in KLoSA, and 1.65 (95%CI 1.31 to 2.07) in IFLS. However, with adjustment of potential confounders, the corresponding HRs dropped to 1.07 (95%CI 0.94 to 1.20) in ELSA, 1.08 (95%CI 0.97 to 1.22) in SHARE, 0.91 (95%CI 0.77 to 1.08) in KLoSA, and 0.89 (95%CI 0.66 to 1.21) in IFLS, respectively.

Conclusions

In these four population-based longitudinal studies, no association between symptomatic knee osteoarthritis and increased risk of all-cause mortality was observed after adjusting for potential confounders.
Key Points
• This study evaluated the association between symptomatic knee OA and the risk of all-cause mortality among the participants retrieved from four large population-based longitudinal studies across the world.
• No association between symptomatic knee osteoarthritis and increased risk of all-cause mortality was observed after considering potential confounders, and our findings were consistent with the results derived from four independent longitudinal studies.
• The present study included four international population-based longitudinal studies, comprising both developed and developing areas, which allowed the findings to be interpreted under larger circumstance.
Appendix
Available only for authorised users
Literature
1.
go back to reference GBD 2015 DALYs and HALE Collaborators (2016) Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388(10053):1603–1658. https://doi.org/10.1016/S0140-6736(16)31460-X CrossRef GBD 2015 DALYs and HALE Collaborators (2016) Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388(10053):1603–1658. https://​doi.​org/​10.​1016/​S0140-6736(16)31460-X CrossRef
2.
go back to reference GBD 2016 Disease and Injury Incidence and Prevalence Collaborators (2017) Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390(10100):1260–1344. https://doi.org/10.1016/S0140-6736(17)32130-X CrossRef GBD 2016 Disease and Injury Incidence and Prevalence Collaborators (2017) Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390(10100):1260–1344. https://​doi.​org/​10.​1016/​S0140-6736(17)32130-X CrossRef
4.
go back to reference Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill CL, Laslett LL, Jones G, Cicuttini F, Osborne R, Vos T, Buchbinder R, Woolf A, March L (2014) The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73(7):1323–1330. https://doi.org/10.1136/annrheumdis-2013-204763 CrossRefPubMed Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill CL, Laslett LL, Jones G, Cicuttini F, Osborne R, Vos T, Buchbinder R, Woolf A, March L (2014) The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73(7):1323–1330. https://​doi.​org/​10.​1136/​annrheumdis-2013-204763 CrossRefPubMed
5.
go back to reference Kadam UT, Jordan K, Croft PR (2004) Clinical comorbidity in patients with osteoarthritis: a case-control study of general practice consulters in England and Wales. Ann Rheum Dis 63(4):408–414CrossRef Kadam UT, Jordan K, Croft PR (2004) Clinical comorbidity in patients with osteoarthritis: a case-control study of general practice consulters in England and Wales. Ann Rheum Dis 63(4):408–414CrossRef
6.
go back to reference van Dijk GM, Veenhof C, Schellevis F, Hulsmans H, Bakker JP, Arwert H, Dekker JH, Lankhorst GJ, Dekker J (2008) Comorbidity, limitations in activities and pain in patients with osteoarthritis of the hip or knee. BMC Musculoskelet Disord 9:95. https://doi.org/10.1186/1471-2474-9-95 van Dijk GM, Veenhof C, Schellevis F, Hulsmans H, Bakker JP, Arwert H, Dekker JH, Lankhorst GJ, Dekker J (2008) Comorbidity, limitations in activities and pain in patients with osteoarthritis of the hip or knee. BMC Musculoskelet Disord 9:95. https://​doi.​org/​10.​1186/​1471-2474-9-95
7.
go back to reference Nielen MM, van Sijl AM, Peters MJ, Verheij RA, Schellevis FG, Nurmohamed MT (2012) Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care. BMC Musculoskelet Disord 13:150. https://doi.org/10.1186/1471-2474-13-150 Nielen MM, van Sijl AM, Peters MJ, Verheij RA, Schellevis FG, Nurmohamed MT (2012) Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care. BMC Musculoskelet Disord 13:150. https://​doi.​org/​10.​1186/​1471-2474-13-150
8.
go back to reference Nitter A, Forseth K (2013) Mortality rate and causes of death in women with self-reported musculoskeletal pain: results from a 17-year follow-up study. Scand J Pain 4(2):86–92CrossRef Nitter A, Forseth K (2013) Mortality rate and causes of death in women with self-reported musculoskeletal pain: results from a 17-year follow-up study. Scand J Pain 4(2):86–92CrossRef
9.
go back to reference Macfarlane GJ, McBeth J, Silman AJ (2001) Widespread body pain and mortality: prospective population based study. BMJ 323(7314):662–665CrossRef Macfarlane GJ, McBeth J, Silman AJ (2001) Widespread body pain and mortality: prospective population based study. BMJ 323(7314):662–665CrossRef
20.
go back to reference Alcser KH, Benson G, Börsch-Supan A, Brugiavini A, Christelis D, Croda E, Das M, de Luca G, Harkness J, Hesselius P, Jappelli T, Jürges H, Kalwij A, Kemperman ML, Klevmarken A, Lipps O, Paccagnella O, Padula M, Perrachi F, Rainato R, van Soest A, Swensson B, Vis C, Weber G, Weerman B (2005) The Survey of Health, Aging, and Retirement in Europe – Methodology. http://www.share-project.org/data-documentation/methodology-volumes.html. Accessed 26 Nov 2018 Alcser KH, Benson G, Börsch-Supan A, Brugiavini A, Christelis D, Croda E, Das M, de Luca G, Harkness J, Hesselius P, Jappelli T, Jürges H, Kalwij A, Kemperman ML, Klevmarken A, Lipps O, Paccagnella O, Padula M, Perrachi F, Rainato R, van Soest A, Swensson B, Vis C, Weber G, Weerman B (2005) The Survey of Health, Aging, and Retirement in Europe – Methodology. http://​www.​share-project.​org/​data-documentation/​methodology-volumes.​html. Accessed 26 Nov 2018
30.
go back to reference Hochberg MC (2008) Mortality in osteoarthritis. Clin Exp Rheumatol 26(5 Suppl 51):S120–S124PubMed Hochberg MC (2008) Mortality in osteoarthritis. Clin Exp Rheumatol 26(5 Suppl 51):S120–S124PubMed
33.
go back to reference GBD (2016) Disease and Injury Incidence and Prevalence Collaborators (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390(10100):1211–1259. https://doi.org/10.1016/S0140-6736(17)32154-2 CrossRef GBD (2016) Disease and Injury Incidence and Prevalence Collaborators (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390(10100):1211–1259. https://​doi.​org/​10.​1016/​S0140-6736(17)32154-2 CrossRef
Metadata
Title
Does symptomatic knee osteoarthritis increase the risk of all-cause mortality? Data from four international population-based longitudinal surveys of aging
Authors
Zidan Yang
Guanghua Lei
Xiaoxiao Li
Yilun Wang
Zikun Xie
Xiurui Zhang
Yuchen He
Yilin Xiong
Tubao Yang
Publication date
01-11-2019
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 11/2019
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-019-04672-5

Other articles of this Issue 11/2019

Clinical Rheumatology 11/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.